About Raffles
Based in Guangdong China, we are enabling our pharma and fine chemicals clients to achieve more.   
Services
From early stage development to product launch, we support companies around the world.
Expertise
In addition to the broad variety of molecules we provide, have built focused capabilities in a few select areas. 
Sites
Learn more about our existing sites in Guangdong China, and our new manufacturing site in progress.
News and Events
Sharing our experiences with industry events and publications.  
Contact Us
Want to connect with someone about a molecule? or looking for your next career opportunity?
Hwagen/Raffles Completed Series A Round of Funding.
May 5th,2020

Hwagen/Raffles Completed Series A Round of Funding.

Raffles parent company, Shenzhen Hwagen Pharmaceutical Co.,Ltd (Hwagen) completed a Series A round of funding valued at RMB 100 million in April 2020. The funds will be used to expand the R&D platform, with an additional 6,500 square meters of R&D space, and construct the new cGMP production site in Daya bay, Huizhou (Dayawan-2 Site). The new cGMP facility covers an area of 28,000 square meters, with a total investment of RMB 300 million.

opyright © Raffles PharmaTech Co., Ltd. All Rights Reserved. Record Guangdong ICP44139902100016 No.